Emergent Biosolutions Inc News - EBS | ADVFN

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
Emergent Biosolutions Inc (EBS)
Emergent Biosolutions Inc (EBS) News

Emergent Biosolutions Inc (EBS)

5.27

-0.44

(-7.71%)

Closed May 16 4:00PM

Delayed by 15 minutes

5.32

0.05

(0.95%)

After Hours: 7:24PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying...

Form 8-K - Current report

Form 8-K - Current report

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company...

Wall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and More

U.S. index futures remained firm and stable in the pre-market on Wednesday, as investors closely watched the...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced...

joyceschoice

joyceschoice 13 hours ago

My apologies I posted the wrong charts in my post yesterday.

https://elite.finviz.com/quote.ashx?t=EBS&ty=c&ta=1&p=d
https://stockcharts.com/freecharts/gallery.html?EBS

TrendTrade2016

TrendTrade2016 18 hours ago

Gapping. Let’s see the break!

joyceschoice

joyceschoice 1 day ago

It is kinda sweet.

https://elite.finviz.com/quote.ashx?t=HRTX&ty=c&ta=1&p=d
https://stockcharts.com/freecharts/gallery.html?hrtx

TrendTrade2016

TrendTrade2016 1 day ago

EBS let’s see another push tomorrow

TrendTrade2016

TrendTrade2016 1 day ago

TrendTrade2016

TrendTrade2016 1 day ago

EBS..THE NEXT BIO BEAST TAKING OFF!!!

TrendTrade2016

TrendTrade2016 2 days ago

EBS...NEXT BIO BEAST!!!

TrendTrade2016

TrendTrade2016 2 days ago

EBS ON THE MOVE

1hot toddy

1hot toddy 1 week ago

15000 SHARE BUY @4.33 $$$$$$$$$$$$$$

Shift-4

Shift-4 2 weeks ago

Here we go, this is what I stuck around here for.

-$

Monksdream

Monksdream 2 weeks ago

allenc

allenc 2 months ago

Taking my chances on IINN now

Monksdream

Monksdream 2 months ago

Probably a good idea

allenc

allenc 2 months ago

I am out. Will wait for a dip and jump back in later this year

Monksdream

Monksdream 2 months ago

You pays your monies and you takes your chances

allenc

allenc 2 months ago

GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2023. Emergent’s newly appointed president and CEO, Joseph C. Papa, will provide remarks.

Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

Monksdream

Monksdream 2 months ago

When is the expected earnings report

allenc

allenc 2 months ago

Hope we see better than expected earnings report

Monksdream

Monksdream 2 months ago

EBS came up off the mat

Monksdream

Monksdream 3 months ago

Well alright then
Socially responsible company
We wait

allenc

allenc 3 months ago

After Market close

Monksdream

Monksdream 3 months ago

Invest-in-America

Invest-in-America 3 months ago

EBS: The hands-down WINNER of this day!!! EASY FRICKIN' MONEY!!!

Monksdream

Monksdream 3 months ago

EBS now No 1 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Monksdream

Monksdream 3 months ago

EBS No 3 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Invest-in-America

Invest-in-America 3 months ago

EBS: Got new CEO, who wants to drive this Firm to the BIG TIME!!

allenc

allenc 3 months ago

Lets see what happens when the financials are released. If they hit their sales target with the OTC Narcan, should be nice net profits, JMO

Monksdream

Monksdream 3 months ago

EBS new 52 week low

allenc

allenc 3 months ago

What is up with this company? Management gonna ride this into the ground and bury it?

Monksdream

Monksdream 4 months ago

EBS new 52 week low

Monksdream

Monksdream 6 months ago

EBS new 52 week low

Monksdream

Monksdream 7 months ago

EBS new 52 week low

Biggiee

Biggiee 7 months ago

Heaping pile of company. Haven’t seen this kind of incompetence in all my years of trading! Narcan everywhere! And this company is collapsing!

Monksdream

Monksdream 7 months ago

EBS new 52 week low

Monksdream

Monksdream 7 months ago

EBS new 52 week low

Biggiee

Biggiee 8 months ago

I’m starting to shift opinions on this… might be a turd of a company. There has to be something seriously rotten here for SP to plummet through 52 week lows.
GL

Biggiee

Biggiee 8 months ago

This has not gone the way it should.
Hmmm….

Biggiee

Biggiee 8 months ago

I’m sure a lot of competitors will try, but Narcan is proven, trusted and ahead of all of them. If this was a race, the $EBS horse is waaaay ahead. I’ve learned to stay clear from really long shot ideas that required a lot a praying. IMO, this is the horse to bet on, especially so near 52 week lows.
GL

Piola

Piola 8 months ago

Hi;
I’m long for EBS. I think it has great potential.
I just have a question. I’ve read that RiVive will come up with its own nasal narcan. Will this have significant impact on EBS?
Doc

Biggiee

Biggiee 9 months ago

18% short interest. This could run big into September when Narcan shows up in stores and gets local/national news
GL $EBS

Biggiee

Biggiee 9 months ago

Narcan for everybody!! $EBS

TheFinalCD

TheFinalCD 10 months ago

https://ih.advfn.com/stock-market/NYSE/emergent-biosolutions-EBS/stock-news/91689294/emergent-biosolutions-awarded-10-year-barda-contra

almost exactly 1 year later

LearningEveryTrade

LearningEveryTrade 2 years ago

Cali State of Emergency https://www.gov.ca.gov/2022/08/01/74502/

Elgordo84

Elgordo84 2 years ago

Looks like this sleeping Giant
Is getting ready to awake!
Let’s go $EBS

InkynClyde

InkynClyde 2 years ago

Building position

Cuppy

Cuppy 3 years ago

"Emergent was forced to halt operations at its plant in the Bayview area of Baltimore after contamination issues led to millions of spoiled vaccine doses."

https://www.nytimes.com/2021/06/16/us/emergent-biosolutions-covid-vaccine.html?action=click&module=Top%20Stories&pgtype=Homepage

since your recommendation, it has lost half its value.

T695

T695 4 years ago

T695

T695 4 years ago

One patient got sick out of 60,000.
Buy buy buy

T695

T695 4 years ago

GoSlowDudes

GoSlowDudes 4 years ago

EPS

2019 $2.88
2020 $6.59
2021 $7.96

P/E = 14.70 on next years earnings. Cheap stock compared to S &P which is in the mid 20’s depending on which one you use.

Emergent Biosolutions

Str PD 6.80 Bmy

RiceBran Technologies

Berkley (W.R.) Corp.

Fortive Corporation

Allarity Therapeutics

Far Peak Acquisition

Quotient Technology

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions